Amica Retiree Medical Trust Trims Stake in STERIS plc (NYSE:STE)

Amica Retiree Medical Trust cut its position in shares of STERIS plc (NYSE:STE) by 6.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,266 shares of the medical equipment provider’s stock after selling 302 shares during the quarter. Amica Retiree Medical Trust’s holdings in STERIS were worth $877,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in STE. Magnolia Capital Advisors LLC raised its stake in shares of STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock worth $521,000 after purchasing an additional 48 shares during the last quarter. SkyView Investment Advisors LLC grew its holdings in STERIS by 1.6% during the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after acquiring an additional 51 shares during the period. Park Edge Advisors LLC lifted its holdings in STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock valued at $958,000 after acquiring an additional 51 shares during the period. Citizens Financial Group Inc. RI boosted its position in STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock worth $201,000 after purchasing an additional 54 shares in the last quarter. Finally, Opal Wealth Advisors LLC grew its stake in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after purchasing an additional 60 shares during the period. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Performance

STE opened at $223.03 on Thursday. The firm’s fifty day simple moving average is $221.95 and its two-hundred day simple moving average is $221.61. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a market cap of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is presently 48.41%.

Wall Street Analyst Weigh In

STE has been the subject of several analyst reports. Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.